Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat. [electronic resource]
Producer: 20200831Description: 19 p. digitalISSN:- 1475-2840
- Animals
- Benzhydryl Compounds -- pharmacology
- Biomarkers -- blood
- Blood Glucose -- drug effects
- Blood Pressure -- drug effects
- Cellular Senescence -- drug effects
- Disease Models, Animal
- Endothelium, Vascular -- drug effects
- Glucosides -- pharmacology
- Metabolic Syndrome -- drug therapy
- Obesity -- complications
- Rats, Zucker
- Sodium-Glucose Transporter 2 Inhibitors -- pharmacology
- Systole
- Ventricular Function, Left -- drug effects
- Ventricular Remodeling -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.